Studies suggest that ketoconazole impairs the synthesis of ergosterol, which is a vital component of fungal cell membranes.
hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Ketoconazole Shampoo, 2% (USRLD: Nizoral® Shampoo ...
to produce the antifungal drug Ketoconazole Shampoo, 2%. The approval is valid for all Zydus Lifesciences affiliates and subsidiaries, said the company in the stock exchange filing dated March ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results